Introduction
Nasal airway obstruction (NAO) is a common presenting symptom in otolaryngology practices and has been described as a source of significant patient discomfort and financial burden.
1,2 Diagnosis of nasal obstruction includes symptom assessment via the Nasal Obstruction Symptom Evaluation (NOSE) instrument 1 and physical exam of the nasal valve, including lateral nasal wall, septum, and inferior turbinates.
Etiologies of nasal obstruction consist of inflammatory and anatomic contributors. 3 Anatomic causes include inferior turbinate hypertrophy, septal deviation, and nasal valve dysfunction. 4 Nasal valve dysfunction can have static and dynamic components, where dynamic nasal valve dysfunction (hereby defined as nasal valve collapse [NVC] ) is caused by lateral wall insufficiency. Many patients have more than one anatomic cause for their nasal obstruction; however, the prevalence of these anatomic causes has not been reported. A survey of patients complaining of nasal obstruction was conducted to establish the prevalence of these anatomic causes.
Patients and methods
Patients' identifying information was not collected; therefore, Institutional Review Board approval was not sought for this survey.
Fifty physicians, including general otolaryngologists, rhinologists, and facial plastic surgeons in various U.S. geographic regions surveyed patients with symptoms of nasal obstruction and/or sinonasal complaints. Data collected included (1) the severity of nasal obstruction, (2) anatomic contributors to nasal obstruction, and (3) history of nasal surgery.
The NOSE instrument was used to assess the severity of nasal obstruction, using five questions, each scored on a scale of 0 to 4. 1 The total NOSE score was converted to a 100-point scale, which defines nasal obstruction severity using a classification system: mild (5 to 25), moderate (30 to 50), severe (55 to 75), or extreme (80 to 100). 5 The patient group with severe or extreme scores was of interest as these patients are potential candidates for intervention.
Three components of the nasal valve anatomy, including the lateral nasal wall, septum, and inferior turbinates, were evaluated by physicians during office visits. The evaluation included an internal nasal exam with direct or endoscopic visualization, based on the physician's standard methodology for diagnosis, and a modified Cottle maneuver. The modified Cottle maneuver (intranasal stabilization of the lateral nasal wall) was performed to gently support the lateral nasal wall cartilage on each side of the nose while the patient was asked to inspire. 6, 7 A modified Cottle maneuver was considered positive if the patient reported improvement in breathing.
Results
A total of 1,906 patients were surveyed by 50 physicians from nine U.S. states (Calif., Fla., Ga., Ill., In., N.C., N.Y., Pa., and Texas). Based on the NOSE scores, most (63%) patients had severe (37%) or extreme (26%) nasal obstruction, 24% reported moderate nasal obstruction, and 11% had mild nasal obstruction. A small number of patients (2%) were asymptomatic.
Most patients had multiple anatomic contributors (table 1) . Among all patients, the prevalence was 67% for NVC, 76% for septal deviation, and 72% for inferior turbinate hypertrophy. The prevalence in the subgroup of patients with severe/extreme nasal obstruction for NVC, septal deviation, and inferior turbinate hypertrophy was 73, 80, and 77%, respectively. Among the patients considered to be symptomatic (severe/extreme nasal obstruction, n = 1,211), 46% presented with NVC, 51% had septal deviation, and 49% had inferior turbinate hypertrophy. Most patients with NVC and inferior turbinate hypertrophy had bilateral contribution (84 and 60%, respectively). Among all patients, septoplasty and/or turbinate reduction procedure history was available for 331 patients. Seventy-one percent (n = 236) of these patients presented with severe/extreme nasal obstruction. The prevalence of NVC in these patients was 82% (table 2) . Eleven patients reported previous lateral nasal wall surgery. Other surgeries reported included functional endoscopic sinus surgery and cosmetic rhinoplasty; these were not analyzed as they are not intended to address anatomic contributors to nasal obstruction.
Discussion
To the best of our knowledge, this is the largest assessment of the prevalence of anatomic contributors to nasal obstruction that has been conducted. The results showed that NVC (73%) was as common as septal deviation (80%) and inferior turbinate hypertrophy (77%) in patients with severe/extreme nasal obstruction. Furthermore, in a subset of patients with severe/extreme nasal obstruction despite prior septoplasty and/or inferior turbinate reduction, NVC prevalence was high (82%), suggesting that missed or untreated NVC may be associated with symptom persistence.
Nasal obstruction is associated with a reduction in quality of life and is a common surgically treated problem. 8, 9 Identification of anatomic contributor(s) is critical for selection of an appropriate treatment strategy. The finding that septal deviation, inferior turbinate hypertrophy, and NVC are common anatomic contributors to nasal obstruction is consistent with the frequency of septoplasty and inferior turbinate reduction procedures performed by otolaryngologists. 10, 11 Unfortunately, surgery is associated with diminished satisfaction and persistent nasal obstruction over time. 12, 13 Furthermore, a fraction of the patients with NAO who were ideal candidates for septoplasty did not achieve significant improvement after the procedure. 1, 14 Although these results show that NVC is an equally prevalent anatomic contributor, analysis of commercial payer and Medicare fee-for-service data indicates that its surgical correction is less frequent than septoplasty and inferior turbinate reduction. A potential explanation for this divergence in treatment is infrequent screening for NVC.
Most patients with nasal obstruction have multiple anatomic contributors, and diagnoses of septal deviation and inferior turbinate hypertrophy are commonly achieved; however, surgical techniques to address these anatomic contributors do not directly address weakness in the lateral nasal wall. 15 The NVC clinical consensus statement published in 2010 concluded that NVC is a distinct etiology for nasal obstruction and that the validity of the modified Cottle maneuver for identifying NVC suggests suitability for inclusion in examinations. 6 Previous reports of patients who underwent revision septoplasty and who suffered from persistent nasal obstruction after their primary septoplasty showed that NVC was highly prevalent and frequently required correction during the revision surgery. 16 This finding, coupled with high prevalence rates in patients with severe/extreme nasal obstruction, suggests that more routine diagnosis of NVC may inform optimal treatment for patients.
Treatment options for NVC include invasive cartilaginous grafts, such as batten grafts and lateral crural strut grafts, and less invasive options, such as absorbable nasal implants. Temporary, noninvasive options include nasal strips and dilators. This survey did not examine the outcomes of the treatment options.
This survey showed that the prevalence of NVC was as common as the prevalence of septal deviation and inferior turbinate hypertrophy in patients with nasal obstruction. Therefore, assessment of all anatomic contributors, including NVC, is critical to ensure adequate symptom reduction. 
